Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period

Nephrology Dialysis Transplantation

Volumn 31, Issue 1, 2016, Pages 120-128

  Van De Luijtgaarden, Moniek W M ^a   Jager, Kitty J ^a   Segelmark, Mårten ^b   Pascual, Julio ^c   Collart, Frederic ^d   Hemke, Aline C ^e   Remón, César ^f   Metcalfe, Wendy ^g   Miguel, Alfonso ^h   Kramar, Reinhard ⁱ   Aasarød, Knut ^j   Abu Hanna, Ameen ^a   Krediet, Raymond T ^a   Schön, Staffan ^k   Ravani, Pietro ^l   Caskey, Fergus J ^m   Couchoud, Cecile ⁿ   Palsson, Runolfur ^o,p   Wanner, Christoph ^a,q   Finne, Patrik ^r   Noordzij, Marlies ^a   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LINKÖPING UNIVERSITY   (Sweden)

^c HOSPITAL DEL MAR   (Spain)

^d French Speaking Belgium Renal Registry   (Belgium)

^e Nefrovisie Renine   (Netherlands)

^f SICATA (The Information System of the Andalusian Transplant Autonomic Coordination Registry)   (Spain)

^g Scottish Renal Registry   (United Kingdom)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ OEDTR Austrian Dialysis and Transplant Registry   (Austria)

^j TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^k Diaverum Renal Services Group   (Sweden)

^l UNIVERSITY OF CALGARY   (Canada)

^m SOUTHMEAD HOSPITAL   (United Kingdom)

ⁿ AGENCE DE LA BIOMÉDECINE   (France)

^o LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^p UNIVERSITY OF ICELAND   (Iceland)

^q UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^r Finnish Registry for Kidney Diseases   (Finland)

more..

Author keywords

end stage renal disease; haemodialysis; peritoneal dialysis; survival analysis; trends over time

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE REGISTRY; EUROPE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SURVIVAL; SURVIVAL TIME; TREND STUDY; CLINICAL DECISION MAKING; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; REGISTER; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL DECISION-MAKING; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS;

EID: 84960099088     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv295     Document Type: Article

References (42)

1. McDonald SP, Marshall MR, Johnson DWet al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155-163
2. Vonesh EF, Snyder JJ, Foley RN, et al. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?. Kidney Int Suppl 2006; 103: S3-S11
3. Jain AK, Blake P, Cordy P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23: 533-544
4. Khawar O, Kalantar-Zadeh K, Lo WK, et al. Is the declining use of long-Term peritoneal dialysis justified by outcome data?. Clin J Am Soc Nephrol 2007; 2: 1317-1328
5. Mehrotra R, Kermah D, Fried L, et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007; 18: 2781-2788
6. Noordzij M, Jager KJ. Survival comparisons between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 2012; 27: 3385-3387
7. van de Luijtgaarden MW, Jager KJ, Stel VS, et al. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant 2013; 28: 1264-1275
8. Wang V, Lee SY, Patel UD, et al. Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003. Am J Kidney Dis 2010; 55: 1079-1087
9. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27: 3568-3575
10. Parsons LS. Performing a 1: N Case-Control Match on propensity score. SAS Institute Inc 2004 Proceedings of the Twenty-Ninth Annual SAS® Users Group International Conference 2004. SAS Institute Inc., Cary, NC
11. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc., 1980
12. Noordzij M, Leffondre K, van Stralen KJ, et al. When do we need competing risks methods for survival analysis in nephrology?. Nephrol Dial Transplant 2013; 28: 2670-2677
13. Couchoud C, Bolignano D, Nistor I, et al. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic reviewof the available evidence. Nephrol Dial Transplant 2015; 30: 310-320
14. Perl J, Wald R, Bargman JM, et al. Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol 2012; 7: 1145-1154
15. Pulliam J, Li NC, Maddux F, et al. First-year outcomes of incident peritoneal dialysis patients in the United States. Am J Kidney Dis 2014; 64: 761-769
16. Bernardini J, Piraino B, Holley J, et al. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.AmJ Kidney Dis 1996; 27: 695-700
17. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-2408
18. Owen JE, Walker RG, Lemon J, et al. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 216-220
19. Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-131
20. Krediet RT, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 2010; 6: 451-460
21. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207
22. Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64: 649-656
23. Termorshuizen F, Korevaar JC, Dekker FWet al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302
24. Cho Y, Badve SV, Hawley CMet al. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clin J Am Soc Nephrol 2013; 8: 1556-1563
25. Johnson DW, Brown FG, Clarke M, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23: 1097-1107
26. Kawanishi K, Honda K, Tsukada M, et al.Neutral solution lowin glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int 2013; 33: 242-251
27. Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant 2002; 17: 1655-1660
28. Kolesnyk I, Dekker FW, Boeschoten EWet al. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int 2010; 30: 170-177
29. Flythe JE, Curhan GC, Brunelli SM. Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int 2013; 83: 104-113
30. Tentori F, Zhang J, Li Y, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on incenter three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2012; 27: 4180-4188
31. Jadoul M, Thumma J, Fuller DS, et al. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2012; 7: 765-774
32. Grooteman MP, van den Dorpel MA, Bots ML, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096
33. Vilar E, Fry AC, Wellsted D, et al. Long-Term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J AmSoc Nephrol 2009; 4: 1944-1953
34. Issa N, Lankireddy S, Kukla A. Should peritoneal dialysis be the preferred therapy pre-kidney transplantation?. Adv Perit Dial 2012; 28: 89-93
35. Snyder JJ, Kasiske BL, Gilbertson DT, et al. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002; 62: 1423-1430
36. van de Luijtgaarden MW, Noordzij M, Stel VS, et al. Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant 2011; 26: 2940-2947
37. Karopadi AN, Mason G, Rettore E, et al.Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 2013; 28: 2553-2569
38. Castledine CI, Gilg JA, Rogers Cet al. Renal centre characteristics and physician practice patterns associated with home dialysis use. Nephrol Dial Transplant 2013; 28: 2169-2180
39. Hingwala J, Diamond J, Tangri N, et al. Underutilization of peritoneal dialysis: the role of the nephrologist's referral pattern. Nephrol Dial Transplant 2013; 28: 732-740
40. Jager KJ, Korevaar JC, Dekker FWet al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004; 43: 891-899
41. Brookhart MA, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat 2007; 3: 14
42. Garabedian LF, Chu P, Toh S, et al. Potential bias of instrumental variable analyses for observational comparative effectiveness research. Ann Intern Med 2014; 161: 131-138